Atossa Therapeutics, Inc. (ATOS): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2015-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$1.8K
Year ended 2015-12-31
-84.6%
3-year compound annual growth
$632.6K2011-12-31: $1.5K2012-12-31: $481.8K2013-12-31: $632.6K2014-12-31: $40.1K2015-12-31: $1.8K$1.8K
2011-12-31 Revenue (USD) 2015-12-31
Period endedRevenueChange YoYSource filing
2015-12-31$1.8K-95.6%2017-03-21, From 2015-01-01
2014-12-31$40.1K-93.7%2016-03-30, From 2014-01-01
2013-12-31$632.6K+31.3%2015-03-30, From 2013-01-01
2012-12-31$481.8Kn/m2014-03-27, From 2012-01-01
2011-12-31$1.5Kn/a2013-03-28, From 2011-01-01